These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11365570

  • 1. FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration.
    Baker R.
    BETA; 1998 Jul; ():8-9. PubMed ID: 11365570
    [Abstract] [Full Text] [Related]

  • 2. Rooting out institutional corruption to manage inappropriate off-label drug use.
    Rodwin MA.
    J Law Med Ethics; 2013 Jul; 41(3):654-64. PubMed ID: 24088156
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J, Brophy E, Rother P.
    Food Drug Law J; 2008 Jul; 63(2):391-406. PubMed ID: 18561466
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulating off-label drug use--rethinking the role of the FDA.
    Stafford RS.
    N Engl J Med; 2008 Apr 03; 358(14):1427-9. PubMed ID: 18385495
    [No Abstract] [Full Text] [Related]

  • 8. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Proposed rule.
    Fed Regist; 1998 Jun 08; 63(109):31143-61. PubMed ID: 10180130
    [Abstract] [Full Text] [Related]

  • 9. Off-label uses of drugs and medical devices: should the FDA crack down?
    Margolis RE.
    Healthspan; 1993 Jan 08; 10(1):18-9. PubMed ID: 10124289
    [No Abstract] [Full Text] [Related]

  • 10. Origins of the prohibition against off-label promotion.
    Coleman TS.
    Food Drug Law J; 2014 Jan 08; 69(2):161-236, i. PubMed ID: 25163210
    [Abstract] [Full Text] [Related]

  • 11. Off-label prescribing among office-based physicians.
    Radley DC, Finkelstein SN, Stafford RS.
    Arch Intern Med; 2006 May 08; 166(9):1021-6. PubMed ID: 16682577
    [Abstract] [Full Text] [Related]

  • 12. Off label drug promotion.
    Body Posit; 1998 Oct 08; 11(10):11. PubMed ID: 11365909
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amendment of regulations regarding certain label statements on prescription drugs. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Feb 01; 67(22):4904-7. PubMed ID: 11829025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey.
    Chen DT, Wynia MK, Moloney RM, Alexander GC.
    Pharmacoepidemiol Drug Saf; 2009 Nov 01; 18(11):1094-100. PubMed ID: 19697444
    [Abstract] [Full Text] [Related]

  • 18. The new FDA pregnancy labeling requirements for drugs.
    Frederiksen MC.
    J Midwifery Womens Health; 2011 Nov 01; 56(3):303-7. PubMed ID: 21535377
    [Abstract] [Full Text] [Related]

  • 19. Uses of drugs not described in the package insert (off-label uses).
    Committee on Drugs. American Academy of Pediatrics.
    Pediatrics; 2002 Jul 01; 110(1 Pt 1):181-3. PubMed ID: 12093968
    [Abstract] [Full Text] [Related]

  • 20. Off-label drugs: question your doctor.
    Consum Rep; 2007 Jun 01; 72(6):47. PubMed ID: 17632948
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.